Company Filing History:
Years Active: 2012-2017
Title: Mark Pierce: Innovator in Iontophoretic Treatments
Introduction
Mark Pierce is a notable inventor based in Essex, CT (US), recognized for his contributions to the field of medical treatments. He holds 5 patents that focus on innovative methods for treating nausea and migraine through iontophoretic techniques. His work has significantly advanced the understanding and application of pharmacokinetics in drug delivery systems.
Latest Patents
Among his latest patents, Mark has developed methods for iontophoretically treating nausea and migraine. These methods involve the iontophoretic administration of triptan compounds, providing a new avenue for patients suffering from these conditions. Additionally, he has described improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan, enhancing the effectiveness of this treatment.
Career Highlights
Mark has worked with prominent companies in the pharmaceutical industry, including Nupathe Inc. and Teva Pharmaceuticals International GmbH. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug delivery systems.
Collaborations
Some of Mark's notable coworkers include Terri Sebree and Carol O'Neill. Their collaborative efforts have played a crucial role in the development of innovative treatments in the field.
Conclusion
Mark Pierce's work in iontophoretic treatments showcases his dedication to improving patient care through innovative solutions. His patents and collaborations reflect a commitment to advancing medical technology and enhancing the quality of life for individuals suffering from nausea and migraine.